Why Join the Antigen-Specific Immune Tolerance Summit for the 10th Anniversary Edition:
For 10 years, the Antigen-Specific Immune Tolerance Summit has brought together leaders to advance targeted approaches for autoimmune disease. This year, attendees will gain exclusive insight into the latest emerging trial data, next-generation delivery platforms, and novel tolerance-inducing approaches.
Dedicated sessions will tackle some of the biggest bottlenecks limiting clinical success, with insights from biomarker experts, translational scientists, and therapy developers who will share practical strategies to accelerate development and overcome regulatory and clinical hurdles. Participating will provide a unique opportunity to benchmark progress, challenge current thinking, and shape the next generation of antigen-specific immune tolerance therapies.
This year, the summit will be part of World Immune Tolerance Week, alongside the 9th Treg Directed Therapies Summit and the Immune Reset: B Cell Mediated & Beyond Summit, to provide the industry’s most comprehensive immune tolerance gathering.
Unmissable Event Highlights
Clinical Lessons for Tolerance Development
Explore exclusive clinical lessons from Diamyd Medical and COUR Pharmaceuticals to uncover practical insights and strengthen development plans to guide your path to the clinic.
Tolerance Biomarkers & Monitoring
Gain practical insights into monitoring tolerizing therapies and biomarkers of tolerance from King’s College London and the Immune Tolerance Network to improve efficacy assessment and strenghen clinical endpoints.
EBV, Autoimmunity & Tolerance Therapy
Learn how emerging evidence on EBV and autoimmunity could reshape tolerance therapy design, equipping you with insights that may provide a competitive edge as the field evolves.
Predicting Clinical Success from Preclinical Models
Learn how to better predict tolerizing therapy performance in human trials using preclinical models, helping you make more informed development decisions and reduce translational risk, with insights from COUR Pharmaceuticals and LoopLab.
Explore the Full Event Guide
- Gain a first look at the 2027 ASIT priorities shaping the future of immune tolerance and identify where you fit within the evolving landscape
- Discover dedicated workshop sessions focused on biomarkers of tolerance, pre-clinical models, and translational development
- Look forward to a panel dedicated to investment readiness to help de-risk and accelerate therapeutic development
- Maximize your on-site experience and connect with a broad network of autoimmune and immunology leaders as part of World Immune Tolerance Week
Attending Companies Include
New for 2027: World Immune Tolerance Week
For the very first time, the 10th Antigen-Specific Immune Tolerance Summit is becoming part of World Immune Tolerance Week alongside the 9th Treg-Directed Therapies Summit and the 2nd Immune Resetting: B-Cell Mediated & Beyond Summit to bring together the full autoimmune and immunology disease community. While each summit retains its own scientific focus, expert speaker faculty, and community, attendees will gain access to all three meetings, enabling cross-disciplinary learning, richer networking, and collaboration across antigen-specific therapies, Treg approaches, B-cell modulation, and broader immune resetting strategies.
Advancing Transformative Therapies to Reset Autoimmune Diseases
Expand the Application of Treg Therapies into a Clinical Reality
Accelerating Curative Therapies for Autoimmune Diseases
Explore the Agenda
Hear the latest clinical developments from industry experts and gain exclusive insights from the packed agenda, interactive roundtables, and panel discussions.
Partner with the World Immune Tolerance Week
Position yourself alongside other leading solution providers to ensure your brand is at the heart immunology and autoimmune disease advancements.
Join a Community of Immunology Experts
Position your organization alongside the leading innovators, developers, and technology providers advancing the future of immune tolerance and autoimmune disease treatment.